Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation

Journal of Virology

Volumn 68, Issue 9, 1994, Pages 5638-5647

  Nielsen, Anders Lade ^a   Pallisgaard, Niels ^a   Pedersen, Finn Skou ^a   Jørgensen, Poul ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; DNA BINDING; DNA TRANSFECTION; ELECTROPHORETIC MOBILITY; FRIEND LEUKEMIA VIRUS; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; SPLEEN FOCUS FORMING VIRUS; VIRUS TRANSCRIPTION;

EID: 0028129965     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.9.5638-5647.1994     Document Type: Article

References (75)

1. Andrews, N. C., and D. V. Fallen 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
2. Aronheim, A., H. Ohlsson, C. W. Park, T. Edlund, and M. D. Walker. 1991. Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic β cells and lymphocytes. Nucleic Acids Res. 19:3893-3899.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1989. Current protocols in molecular biology. Greene Associates, New York.
4. Benezra, R., R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
5. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
6. Blackwell, T. K., and H. Weintraub. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104-1110.
7. Celander, D., and W. A. Haseltine. 1984. Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses. Nature (London) 312:159-162.
8. Celander, D., and W. A. Haseltine. 1987. Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region. J. Virol. 61:269-275.
9. Celander, D., B. L. Hsu, and W. A. Haseltine. 1988. Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness. J. Virol. 62:1314-1322.
10. Chatis, P. A., C. A. Holland, J. W. Hartley, W. P. Rowe, and N. Hopkins. 1983. Role for the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. USA 80:4408-4411.
11. Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Frederickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:248-254.
12. Christy, B. A., L. K. Sanders, L. F. Lau, N. G. Copeland, N. A. Jenkins, and D. Nathans. 1991. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. USA 88:1815-1819.
13. Clark, S. P., and T. W. Mak. 1982. Nucleotide sequences of the murine retrovirus Friend SFFVp long terminal repeats: identification of a structure with extensive dyad symmetry 5′ to the TATA box. Nucleic Acids Res. 10:3315-3330.
14. Corneliussen, B., A. Thornell, B. Hallberg, and T. Grundstrom. 1991. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65:6084-6093.
15. DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945-952.
16. DesGroseillers, L., R. Villemur, and P. Jolicoeur. 1983. The high leukemogenic potential of Gross passage A murine leukemia virus maps in the region of the genome corresponding to the long terminal repeat and to the 3′ end of env. J. Virol. 47:24-32.
17. Duch, M., K. Paludan, J. Lovmand, L. Pedersen, P. Jorgensen, and F. S. Pedersen. 1993. A correlation between dexamethasone inducibility and basal expression levels of retroviral proviruses. Nucleic Acids Res. 21:4777-4782.
18. Golemis, E. A., N. A. Speck, and N. Hopkins. 1990. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:534-542.
19. Hall, C. V., P. E. Jacob, G. M. Ringold, and F. Lee. 1983. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells. J. Mol. Appl. Genet. 2:101-109.
20. Hallberg, B., J. Schmidt, A. Luz, F. S. Pedersen, and T. Grundstrom. 1991. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J. Virol. 65:4177-4181.
21. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
22. Henthorn, P., M. Kiledjian, and T. Kadesch. 1990. Two distinct transcription factors that bind the immunoglobulin enhancer μE5/κE2 motif. Science 247:467-470.
23. Hsu, H.-L., L. Huang, J. T. Tsan, W. Funk, W. E. Wright, J.-S. Hu, R. E. Kingston, and R. Baer. 1994. Preferred sequences for DNA recognition by the TALI helix-loop-helix proteins. Mol. Cell. Biol. 14:1256-1265.
24. Hu, J.-S., E. N. Olson, and R. E. Kingston. 1992. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol. Cell. Biol. 12:1031-1042.
25. Ishimoto, A., M. Takimoto, A. Adachi, M. Kakuyama, S. Kato, K. Kakimi, K. Fukuoka, T. Ogiu, and M. Matsuyama. 1987. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses. J. Virol. 61:1861-1866.
26. Jacobs, Y., C. Vierra, and C. Nelson. 1993. E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development. Mol. Cell. Biol. 13:7321-7333.
27. Janowski, M., J. Merregaert, J. Bonvier, and J. R. Maisin. 1985. Proviral genome of radiation leukemia virus: molecular cloning of biologically active proviral DNA and nucleotide sequence of its long terminal repeat. J. Virol. 55:251-255.
28. Jen, Y., H. Weintraub, and R. Benezra. 1992. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 6:1466-1479.
29. Klein, E. S., D. M. Simmons, L. W. Swanson, and M. G. Rosenfeld. 1993. Tissue-specific RNA splicing generates an ankyrin-like domain that affects the dimerization and DNA-binding properties of a bHLH protein. Genes Dev. 7:55-71.
30. Koch, W., W. Zimmermann, A. Oliff, and R. Friedrich. 1984. Molecular analysis of the envelope gene and long terminal repeat of Friend mink cell focus-inducing virus: implications for the functions of these sequences. J. Virol. 49:828-840.
31. Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
32. Lenardo, M., J. W. Pierce, and D. Baltimore. 1987. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236:1573-1577.
33. Lenz, J., D. Gelander, R. L. Crowther, R. Patarca, D. W. Perkins, and W. A. Haseltine. 1984. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature (London) 308:467-470.
34. Lenz, J., R. Crowther, S. Klimenko, and W. Haseltine. 1982. Molecular cloning of a highly leukemogenic, ecotropic retrovirus from an AKR mouse. J. Virol. 43:943-951.
35. Li, Y., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:693-700.
36. Linemeyer, D. L., J. G. Menke, S. K. Ruscetti, L. H. Evans, and E. M. Scolnick. 1982. Envelope gene sequences which encode the gp52 protein of spleen focus-forming virus are required for the induction of erythroid cell proliferation. J. Virol. 43:223-233.
37. Lovmand, S., N. O. Kjeldgaard, P. Jørgensen, and F. S. Pedersen. 1990. Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences. J. Virol. 64:3185-3191.
38. Manley, N. R., M. O'Connell, W. Sun, N. A. Speck, and N. Hopkins. 1993. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers. J. Virol. 67:1967-1975.
39. Manley, N. R., M. A. O'Connell, P. A. Sharp, and N. Hopkins. 1989. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus. J. Virol. 63:4210-4223.
40. Miksicek, R., A. Heber, W. Schmid, U. Danesch, G. Posseckert, M. Beato, and G. Schutz. 1986. Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus. Cell 46:283-290.
41. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
42. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-783.
43. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, and A. B. Lassar. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
44. Murre, C., A. Voronova, and D. Baltimore. 1991. B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like sub-units. Mol. Cell. Biol. 11:1156-1160.
45. Nelsen, B., G. Tian, B. Erman, J. Gregoire, R. Maki, B. Graves, and R. Sen. 1993. Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS-domain proteins. Science 261:82-86.
46. Nelson, C., L. P. Shen, A. Meister, E. Fodor, and W. J. Rutter. 1990. Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev. 4:1035-1043.
47. Nielsen, A. L., N. Pallisgaard, F. S. Pedersen, and P. Jørgensen. 1992. Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol. Cell. Biol. 12:3449-3459.
48. Norby, P. L., N. Pallisgaard, F. S. Pedersen, and P. Jorgensen. 1992. Determination of recognition-sequences for DNA-binding proteins by a polymerase chain reaction assisted binding site selection method (BSS) using nitrocellulose immobilized DNA binding protein. Nucleic Acids Res. 20:6317-6321.
49. Olsen, H. S., S. Lovmand, J. Lovmand, P. Jørgensen, N. O. Kjeldgaard, and F. S. Pedersen. 1990. Involvement of nuclear factor I-binding sites in control of Akv virus gene expression. J. Virol. 64:4152-4161.
50. Pallisgaard, N., F. S. Pedersen, S. Birkelund, and P. Jorgensen. 1994. A common multiple cloning site in a set of vectors for expression of eukaryotic genes in mammalian, insect and in bacterial cells. Gene 138:115-118.
51. Paludan, K., H. Y. Dai, M. Duch, P. Jorgensen, N. O. Kjeldgaard, and F. S. Pedersen. 1989. Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses. J. Virol. 63:5201-5207.
52. Pongubala, J. M. R., and M. L. Atchison. 1991. Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol. Cell. Biol. 11:1040-1047.
53. Rivera, R. R., M. H. Stuiver, R. Steenbergen, and C. Murre. 1993. Ets proteins: new factors that regulate immunoglobulin heavychain gene expression. Mol. Cell. Biol. 13:7163-7169.
54. Rosen, C. A., W. A. Haseltine, J. Lenz, R. Ruprecht, and M. W. Cloyd. 1985. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55:862-866.
55. Ruta, M., R. Bestwick, C. Machida, and D. Rabat. 1983. Loss of leukemogenicity caused by mutations in the membrane glycoprotein structural gene of Friend spleen focus-forming virus. Proc. Natl. Acad. Sci. USA 80:4704-4708.
56. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
57. Sawada, S., and D. R. Littman. 1993. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13:5620-5628.
58. Shinnick, T. M., R. A. Lerner, and J. G. Sutcliffe. 1981. Nucleotide sequence of Moloney murine leukemia virus. Nature (London) 293:543-548.
59. Short, M. K., S. A. Okenquist, and J. Lenz. 1987. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats. J. Virol. 61:1067-1072.
60. Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1101-1110.
61. Speck, N. A., B. Renjifo, E. Golemis, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233-242.
62. Speck, N. A., B. Renjifo, and N. Hopkins. 1990. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J. Virol. 64:543-550.
63. Spiro, C., J. P. Li, R. K. Bestwick, and D. Kabat. 1988. An enhancer sequence instability that diversifies the cell repertoire for expression of a murine leukemia virus. Virology 164:350-361.
64. Sun, X. H., and D. Baltimore. 1991. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 64:459-470.
65. Sun, X. H., N. G. Copeland, N. A. Jenkins, and D. Baltimore. 1991. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol. Cell. Biol. 11:5603-5611.
66. Van Beveren, C., J. Coffin, and S. Hughes. 1985. Appendix B, p. 567-1221. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses, molecular biology of tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
67. Walker, M. D., C. W. Park, A. Rosen, and A. Aronheim. 1990. A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res. 18: 1159-1166.
68. Weintraub, H., V. J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S. J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes Dev. 5:1377-1386.
69. Weiss, R., N. Teich, H. Varmus, and J. Coffin. 1982. RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
70. Wilson, R. B., M. Kiledjian, C.-P. Shen, R. Benezra, P. Zwollo, S. M. Dymecki, S. V. Desiderio, and T. Kadesch. 1991. Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development. Mol. Cell. Biol. 11:6185-6191.
71. Wolff, L., J. Kaminchik, W. D. Hankins, and S. K. Ruscetti. 1985. Sequence comparisons of the anemia- and polycythemia-inducing strains of Friend spleen focus-forming virus. J. Virol. 53:570-578.
72. Wood, W. B. 1966. Host specificity of DNA produced by Escherichia coli: bacterial mutations affecting the restriction and modification of DNA. J. Mol. Biol. 16:118-133.
73. Wotton, D., J. Ghysdael, S. Wang, N. A. Speck, and M. J. Owen. 1994. Cooperative binding of Ets-1 and core-binding factor to DNA. Mol. Cell. Biol. 14:840-850.
74. Zhang, Y., J. Babin, A. L. Feldbaus, H. Singh, P. A. Sharp, and M. Bina. 1991. HTF4: a new human helix-loop-helix protein. Nucleic Acids Res. 19:4555.
75. Zhang, Y., K. Doyle, and M. Bina. 1992. Interactions of HTF4 with E-box motifs in the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 66:5631-5634.